Shareholders to Vote on Critical BAT Debt-to-Equity Conversion and $10M Investment, Shifting Control

summarizeSummary

Charlotte's Web Holdings, Inc. is seeking shareholder approval for a major transaction with British American Tobacco (BAT) that will convert a C$75.34 million debenture into equity and include a US$10 million equity investment, significantly diluting existing shareholders and giving BAT 40.7% ownership.

check_boxKey Events

• Shareholder Meeting Scheduled

  An Annual General and Special Meeting of Shareholders will be held virtually on May 28, 2026, to vote on several proposals, including a significant transaction with British American Tobacco (BAT).

• Major Debt-to-Equity Conversion Proposed

  Shareholders will vote on amending BAT's C$75.34 million convertible debenture, plus C$14.22 million in accrued interest, to convert into 95,281,277 Common Shares at C$0.94 per share. This follows the 8-K filings on March 31 and April 1, 2026, which announced the agreement.

• US$10 Million Equity Investment from BAT

  A concurrent US$10 million equity investment from BAT will result in the issuance of approximately 14,760,638 Common Shares at C$0.94 per share, providing crucial capital for the company.

• Significant Dilution and Control Shift

  The combined transaction will result in BAT holding 110,041,915 Common Shares, representing 40.7% of the estimated 270,580,204 Common Shares outstanding post-transaction. This will make BAT a 'Control Person' and significantly dilute existing shareholders by approximately 68.5% relative to pre-transaction shares.

auto_awesomeAnalysis

This preliminary proxy statement details a critical shareholder vote on a previously announced transaction with British American Tobacco (BAT). The transaction involves converting BAT's C$75.34 million convertible debenture, plus C$14.22 million in accrued interest, into equity and a concurrent US$10 million equity investment. The Board emphasizes that this transaction is essential for the company's financial stability, as it removes its largest liability and injects vital capital. Failure to approve could lead to distressed refinancing or other value-destructive outcomes. While the deal is highly dilutive, resulting in BAT holding 40.7% of post-transaction shares and becoming a 'Control Person,' it provides a necessary capital injection and strengthens a strategic partnership, which the Board views as being in the best interests of the Company.